About Bellerophon Therapeutics
Bellerophon Therapeutics is a company based in Hampton (United States) founded in 2014.. The company has 18 employees as of December 31, 2022. Bellerophon Therapeutics operates in a competitive market with competitors including BTG International, Pulnovo Medical, SoniVie, Aria CV and Adient Medical, among others.
- Headquarter Hampton, United States
- Employees 18 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
$-19.83 M-12as on Dec 31, 2022
-
EBITDA
$-22.38 M-11as on Dec 31, 2022
-
Latest Funding Round
$23.44 M (USD), Post-IPO
Oct 09, 2017
-
Investors
Linde Group
& 3 more
-
Employee Count
18
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Bellerophon Therapeutics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $23.4M
-
First Round
First Round
(27 Sep 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2017 | Amount | Post-IPO - Bellerophon Therapeutics | Valuation |
investors |
|
| Sep, 2017 | Amount | Post-IPO - Bellerophon Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bellerophon Therapeutics
Bellerophon Therapeutics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Linde Group, Puissance Capital and New Mountain Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
New Mountain Capital manages investments in private equity, credit, and net lease strategies.
|
Founded Year | Domain | Location | |
|
VC & PE firm focused on healthcare sector
|
Founded Year | Domain | Location | |
|
Manages diversified investment portfolios across multiple asset classes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bellerophon Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bellerophon Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bellerophon Therapeutics Comparisons
Competitors of Bellerophon Therapeutics
Bellerophon Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BTG International, Pulnovo Medical, SoniVie, Aria CV and Adient Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
|
|
| domain | founded_year | HQ Location |
A medical device for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
A denervation catheter for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Device for pulmonary hypertension
|
|
| domain | founded_year | HQ Location |
Bioabsorbable medical devices are developed for pulmonary embolism prevention.
|
|
| domain | founded_year | HQ Location |
Retrievable vena cava filters are developed to prevent pulmonary emboli.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bellerophon Therapeutics
Frequently Asked Questions about Bellerophon Therapeutics
When was Bellerophon Therapeutics founded?
Bellerophon Therapeutics was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Bellerophon Therapeutics located?
Bellerophon Therapeutics is headquartered in Hampton, United States. It is registered at Hampton, Virginia, United States.
How many employees does Bellerophon Therapeutics have?
As of Dec 31, 2022, the latest employee count at Bellerophon Therapeutics is 18.
What does Bellerophon Therapeutics do?
Bellerophon Therapeutics is a clinical-stage biotherapeutics company developing products to treat cardiopulmonary and cardiac diseases. Its product, the INOpulse is a combination drug-device therapy that they are developing for the treatment of pulmonary arterial hypertension (PAH), pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), and pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF). The device delivers Nitrous Oxide, a vasodilator into the pulmonary blood vessels, thus dilating them. The company spun out from Ikaria in 2014. Its key products include a nitric oxide delivery device and a bio-absorbable cardiac matrix. Both products are still in development. The company went public in Feb 2015.
Who are the top competitors of Bellerophon Therapeutics?
Bellerophon Therapeutics's top competitors include Pulnovo Medical, SoniVie and BTG International.
Who are Bellerophon Therapeutics's investors?
Bellerophon Therapeutics has 4 investors. Key investors include Linde Group, Puissance Capital, New Mountain Capital, and Venrock Capital Partners.